|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0011854,
umls-concept:C0016365,
umls-concept:C0020615,
umls-concept:C0237401,
umls-concept:C0332307,
umls-concept:C0871261,
umls-concept:C1280500,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2265759,
umls-concept:C2911692,
umls-concept:C2911696
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2008-11-26
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Previous work has demonstrated that chronic administration of the serotonin reuptake inhibitor (SSRI) fluoxetine augments counterregulatory responses to hypoglycemia in healthy humans. However, virtually no information exists regarding the effects of fluoxetine on integrated physiological counterregulatory responses during hypoglycemia in type 1 diabetes. Therefore, the specific aim of this study was to test the hypothesis that 6-week use of the SSRI fluoxetine would amplify autonomic nervous system (ANS) counterregulatory responses to hypoglycemia in individuals with type 1 diabetes.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-10465693,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-10700699,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-11052960,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-11574457,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-11919662,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-12829642,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-13424687,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-1375306,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-14450081,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-1499656,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-15026569,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-15223272,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-1545373,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-15585598,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-15741747,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-1602007,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-1784347,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-18334609,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-18567822,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-3553949,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-4378854,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-4581053,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-4688625,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-4893149,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-699277,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-7022111,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-7926315,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-8405746,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-9218521,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18835927-9451727
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1939-327X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
57
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3315-22
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18835927-Adult,
pubmed-meshheading:18835927-Diabetes Mellitus, Type 1,
pubmed-meshheading:18835927-Double-Blind Method,
pubmed-meshheading:18835927-Female,
pubmed-meshheading:18835927-Fluoxetine,
pubmed-meshheading:18835927-Homeostasis,
pubmed-meshheading:18835927-Humans,
pubmed-meshheading:18835927-Hypoglycemia,
pubmed-meshheading:18835927-Insulin,
pubmed-meshheading:18835927-Male,
pubmed-meshheading:18835927-Middle Aged,
pubmed-meshheading:18835927-Serotonin Uptake Inhibitors,
pubmed-meshheading:18835927-Young Adult
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes.
|
|
pubmed:affiliation |
Department of Medicine, Vanderbilt University, Nashville, TN, USA.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, N.I.H., Extramural
|
